INKmune™ is a biologic delivery system that allows for the delivery of essential priming signals to patients’ resting NK cells. INKmune™ is delivered by a simple IV infusion. Once in the patient’s system, INKmune™ comes in contact with resting NK cells. The interaction converts NK cells to “primed NK cell” (PiNK) similar to an “on-off” switch. PiNK then remain primed until they contact and kill cancer cells.